When evaluating the TROP2 score based on immunohistochemical (IHC) staining (Fig. 3A), a significantly higher TROP2 score was observed in the tumor samples compared to adjacent non-tumor samples and normal tissue (Fig. 3B–D). This evidence concerns the gene TACSTD2 and neoplasm.